Basaglar and Lactulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Basaglar (insulin glargine) and Lactulose (lactulose). Common drug interactions include swelling among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Basaglar and Lactulose. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.



On Jul, 27, 2026

34 people who take Basaglar and Lactulose together, and have interactions are studied.

Basaglar and Lactulose drug interactions.

What are the common drug interactions of Basaglar and Lactulose, by gender? *:

female:

  1. Swelling
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Urinary tract infection
  4. Death
  5. Chronic kidney disease
  6. Confusional state
  7. Hypersomnia (excessive daytime sleepiness (eds))
  8. Lethargy (tiredness)
  9. Melaena (the passage of black, tarry stools)
  10. Acute respiratory failure

male:

  1. Death
  2. Confusional state
  3. Muscular weakness (muscle weakness)
  4. Pain
  5. Platelet count decreased
  6. Abdominal discomfort
  7. Abdominal distension
  8. Abdominal hernia
  9. Abdominal pain lower
  10. Abdominal pain upper

What are the common drug interactions of Basaglar and Lactulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Muscular weakness (muscle weakness)
  2. Pain
  3. Platelet count decreased

40-49:

n/a

50-59:

  1. Death
  2. Haemoglobin decreased
  3. Confusional state
  4. Hypersomnia (excessive daytime sleepiness (eds))
  5. Lethargy (tiredness)
  6. Melaena (the passage of black, tarry stools)
  7. Acute respiratory failure
  8. Blood bilirubin increased
  9. Blood lactate dehydrogenase increased
  10. Blood pressure increased

60+:

  1. Death
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Abdominal hernia
  4. Abdominal pain lower
  5. Abdominal pain upper
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Asthenia (weakness)
  8. Cough
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 4 people, 11.76%
  2. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 4 people, 11.76%
  3. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 8.82%
  4. Diabetes: 3 people, 8.82%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.88%
  6. Non-Alcoholic Steatohepatitis (liver inflammation caused by a build up of fat in the liver): 2 people, 5.88%
  7. Nausea (feeling of having an urge to vomit): 2 people, 5.88%
  8. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.88%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and Lactulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Basaglar and Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Basaglar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine and lactulose (the active ingredients of Basaglar and Lactulose, respectively), and Basaglar and Lactulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: